Nuvessa (metronidazole) NDC 0642-7466

NDC codes

FDA NDC Directory

Product NDC (as listed)0642-7466Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00642-7466Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0642-7466-05	00642746605	1 APPLICATOR in 1 CARTON (0642-7466-05) / 5 g in 1 APPLICATORMarketed from Mar 10, 2018
0642-7466-06	00642746606	1 APPLICATOR in 1 CARTON (0642-7466-06) / 5 g in 1 APPLICATORMarketed from Mar 10, 2018 · Sample package

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Nuvessa
Generic name (nonproprietary): metronidazole
Active ingredients: Metronidazole — 65 mg/5g
Dosage form: Gel
Route: Topical
Labeler: Exeltis USA, Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 205223
Marketing start: Mar 10, 2018
Listing expires: Dec 31, 2026
Other FDA classes: Nitroimidazoles (Chemical structure)
Identifiers: Product ID 0642-7466_09d13114-f228-f0bc-e063-6394a90a84f5SPL ID 09d13114-f228-f0bc-e063-6394a90a84f5SPL set ID 3b6ff39d-f84b-43b3-9b07-c0521c6d7968RxCUI 1604336, 1608253UNII 140QMO216E
Pharmacologic class: Nitroimidazole Antimicrobial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400642746605 followed by a unit qualifier and the quantity

Package 00642-7466-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 10, 2023.

Indications (excerpt from the label)

NUVESSA is indicated for the treatment of bacterial vaginosis in females 12 years of age and older. NUVESSA is a nitroimidazole antimicrobial indicated for the treatment of bacterial vaginosis in females 12 years of age and older. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)